Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The quest to understand and slow disease ...

Smoldering-associated worsening (SAW) of multiple sclerosis (MS) deserves a broader ... and remain an important unmet ...

For columnist Susan Payrovi, music and dance are key to connecting with others and living a joyful life with multiple ...

The following is a summary of “Assessing and tailoring predictive equations of VO2 max for women with multiple sclerosis with ...

The following is a summary of “A qualitative study on the experiences of autologous haematopoietic stem cell transplant for Multiple Sclerosis,” published in the November 2024 issue of Neurology by ...

In the United States, out-of-pocket (OOP) costs of brand-name medications for neurological disorders increased significantly ...

Multiple sclerosis, a neuroinflammatory disease that affects nearly 3 million people worldwide, causes a loss of myelin, the ...

Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, ...

(Science) A case report assessed the effect of continuous exposure to ofatumumab (Kesimpta) during pregnancy in a patient ...

A higher burden of comorbidities, including 2 or more cardiometabolic diseases, is tied to greater MS disease activity in patients.

The global artificial intelligence (AI) in drug discovery market is projected to reach USD 6.89 billion by 2029 from USD 1.86 ...

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...